Martin Hentemann
Crescent University(NG)CTI BioPharma (Italy)(IT)Foghorn Therapeutics (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Protein Degradation and Inhibitors, Organic Chemistry Cycloaddition Reactions, Asymmetric Synthesis and Catalysis, Oxidative Organic Chemistry Reactions
Most-Cited Works
- → BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models(2013)254 cited
- → Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer(2020)210 cited
- → Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)(2016)113 cited
- → Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region(2014)61 cited
- → A Powerful o-Quinone Dimethide Strategy for Intermolecular Diels−Alder Cycloadditions(2000)54 cited
- → Discovery of Selective and Potent Inhibitors of Gram-Positive Bacterial Thymidylate Kinase (TMK)(2012)54 cited